Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PHAT

Phathom Pharmaceuticals Inc

Apr 30 • 02:28PM ET

11.71

-0.07 -0.59 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NBIX BPMC AXSM BTAI ACAD VKTX MDGL PTGX RDUS XENE

| Held by: VTI IWM VXF XPH IBB IWN SURI SCHA VTWO VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.05	Insider Own	37.29%	Shs Outstand	71.42M	Perf Week	-3.70%
Market Cap	930.13M	Forward P/E	9.41	EPS next Y	1.24	Insider Trans	-0.00%	Shs Float	49.81M	Perf Month	5.40%
Enterprise Value	1.39B	PEG	-	EPS next Q	-0.18	Inst Own	47.66%	Short Float	19.08%	Perf Quarter	-13.45%
Income	-221.25M	P/S	5.31	EPS this Y	86.57%	Inst Trans	5.12%	Short Ratio	8.52	Perf Half Y	-13.52%
Sales	175.11M	P/B	-	EPS next Y	405.77%	ROA	-69.33%	Short Interest	9.50M	Perf YTD	-29.42%
Book/sh	-6.14	P/C	7.16	EPS next 5Y	-	ROE	-	52W High	18.31 -36.05%	Perf Year	172.96%
Cash/sh	1.64	P/FCF	-	EPS past 3/5Y	15.64% 4.82%	ROIC	-179.72%	52W Low	2.21 429.86%	Perf 3Y	9.44%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	87.09%	Volatility	7.77% 6.28%	Perf 5Y	-69.60%
Dividend TTM	-	EV/Sales	7.93	EPS Y/Y TTM	43.00%	Oper. Margin	-91.36%	ATR (14)	0.88	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.69	Sales Y/Y TTM	216.93%	Profit Margin	-126.35%	RSI (14)	47.73	Recom	1.30
Dividend Gr. 3/5Y	- -	Current Ratio	1.73	EPS Q/Q	72.66%	SMA20	-3.82%	Beta	0.61	Target Price	23.70
Payout	-	Debt/Eq	-	Sales Q/Q	94.12%	SMA50	1.45%	Rel Volume	3.32	Prev Close	11.78
Employees	371	LT Debt/Eq	-	Earnings	Apr 30 BMO	SMA200	-6.67%	Avg Volume	1.12M	Price	11.71
IPO	Oct 25, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	38.04% 4.29%	Trades		Volume	2,872,051	Change	-0.59%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)